Article tools
Author information

Research Article

A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

M Ito, Y Mori, Y Oiso and H Saito

First Department of Internal Medicine, Nagoya University School of Medicine, Japan.

Published February, 1991

To elucidate the molecular mechanism of familial central diabetes insipidus (FDI), we sequenced the arginine vasopressin-neurophysin II (AVP-NPII) gene in 2 patients belonging to a pedigree that is consistent with an autosomal dominant mode of inheritance. 10 patients with idiopathic central diabetes insipidus (IDI) and 5 normals were also studied. The AVP-NPII gene, locating on chromosome 20, consists of three exons that encode putative signal peptide, AVP, NPII, and glycoprotein. Using polymerase chain reaction, fragments including the promoter region and all coding regions were amplified from genomic DNA and subjected to direct sequencing. Sequences of 10 patients with IDI were identical with those of normals, while in 2 patients with FDI, a single base substitution was detected in one of two alleles of the AVP-NPII gene, indicating they were heterozygotes for this mutation. It was a G----A transition at nucleotide position 1859 in the second exon, resulting in a substitution of Gly for Ser at amino acid position 57 in the NPII moiety. It was speculated that the mutated AVP-NPII precursor or the mutated NPII molecule, through their conformational changes, might be responsible for AVP deficiency.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Articles that cite this article:

Novel Mutant Vasopressin-neurophysin II Gene Associated with Familial Neurohypophyseal Diabetes Insipidus
Masashi Miyakoshi, Kyuzi Kamoi, Takashi Murase, Yoshihisa Sugimura, Yutaka Oiso
Endocr J 51(6):551. doi:10.1507/endocrj.51.551 [CrossRef]

A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons
Theron A. Russell, Masafumi Ito, Mika Ito, Richard N. Yu, Fred A. Martinson, Jeffrey Weiss, J. Larry Jameson
J Clin Invest 112(11):1697. doi:10.1172/JCI18616 [CrossRef]

Understanding the cause of idiopathic cranial diabetes insipidus: a step forward
P. H. Baylis
Clin Endocrinol (Oxf) 40(2):171. doi:10.1111/j.1365-2265.1994.tb02463.x [CrossRef]

MOLECULAR BIOLOGY OF DIABETES INSIPIDUS
T. Mary Fujiwara, m.sc, Kenneth Morgan, ph.d, Daniel G. Bichet, m.d
Ann Rev Med 46(1):331. doi:10.1146/annurev.med.46.1.331 [CrossRef]

Genetic models of vasopressin deficiency
Frederick D. Grant
Exp Physiol 85(s1):203s. doi:10.1111/j.1469-445X.2000.tb00025.x [CrossRef]

Development of the human hypothalamus
D. F. Swaab
Neurochem Res 20(5):509. doi:10.1007/BF01694533 [CrossRef]

Novel Insights into the Aetiology and Pathogenesis of Hypopituitarism
Mehul T. Dattani
Hormone Res 62(suppl. 3):1. doi:10.1159/000080493 [CrossRef]

Water-Losing and Water-Retaining States
Robert W. Schrier, Melissa A. Cadnapaphornchai, Fuminori Umenishi
Heart Dis 3(3):210. doi:10.1097/00132580-200105000-00014 [CrossRef]

Expression of the Oxytocin and Vasopressin Genes
W. Scott Young
J Neuroendocrinol 4(5):527. doi:10.1111/j.1365-2826.1992.tb00201.x [CrossRef]

Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus
Sridhar Chitturi, Mark Harris, Michael J. Thomsett, Francis Bowling, Ivan Mcgown, David Cowley, Gary M. Leong, Jennifer Batch, Andrew M. Cotterill
Clin Endocrinol (Oxf) 69(6):926. doi:10.1111/j.1365-2265.2008.03303.x [CrossRef]